Breaking the Metabolic Bottleneck: Strategic Intelligence for the Global Argininemia Treatment Market Through 2032 Argininemia, a rare urea cycle disorder driven by arginase 1 deficiency, has long occupied a clinical niche defined by restrictive diets and symptomatic management. For generic manufacturers, specialty pharma investors, and rare-disease developers, this space has historically...